{
    "clinical_study": {
        "@rank": "8131", 
        "acronym": "CALL", 
        "arm_group": [
            {
                "arm_group_label": "Bovine colostrum", 
                "arm_group_type": "Experimental", 
                "description": "A daily supplement of bovine colostrum powder."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A daily placebo supplement consisting of whole milk powder and whey protein."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the present study is to evaluate the ability a colostrum containing diet to limit\n      gastrointestinal toxicity including chemotherapy induced inflammation in children treated\n      for acute lymphoblastic leukemia."
        }, 
        "brief_title": "Effect of Bovine Colostrum on Toxicity and Inflammatory Responses", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Lymphoblastic Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Lymphoid", 
                "Precursor Cell Lymphoblastic Leukemia-Lymphoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "Acute lymphoblastic leukaemia (ALL) is the most common form of childhood cancers. Cure rates\n      are improving, but the intensity of treatment is limited by toxicity. 2-5% of patients die\n      of treatment related complications, mostly related to therapy-induced toxicity and immune\n      suppression. The aim of the present study is to evaluate the ability a colostrum containing\n      diet to limit gastrointestinal toxicity including chemotherapy induced inflammation. The\n      study is based on patients treated according to the current NOPHO protocol."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients treated according to the Nordic Society of Pediatric Haematology and\n             Oncology (NOPHO) ALL protocol\n\n        Exclusion Criteria:\n\n          -  Milk Allergy\n\n          -  Lactose intolerance"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01766804", 
            "org_study_id": "OUH-HCA-002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bovine colostrum", 
                "description": "The intervention consists of daily bovine colostrum supplementation given during the induction treatment of ALL therapy for a total of four weeks.", 
                "intervention_name": "Bovine Colostrum", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Colodan, Biodane-Pharma."
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Acute Lymphoblastic Leukemia", 
            "Bovine Colostrum", 
            "Inflammation", 
            "Infection", 
            "Toxicity"
        ], 
        "lastchanged_date": "May 31, 2013", 
        "location": [
            {
                "contact": {
                    "email": "mathias.rathe@ouh.regionsyddanmark.dk", 
                    "last_name": "Mathias Rathe, MD", 
                    "phone": "+4530296665"
                }, 
                "facility": {
                    "address": {
                        "city": "Copenhagen", 
                        "country": "Denmark", 
                        "zip": "2100"
                    }, 
                    "name": "Rigshospitalet"
                }, 
                "investigator": {
                    "last_name": "Mathias Rathe, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mathias.rathe@ouh.regionsyddanmark.dk", 
                    "last_name": "Mathias Rathe, MD", 
                    "phone": "+4530296665"
                }, 
                "facility": {
                    "address": {
                        "city": "Odense", 
                        "country": "Denmark", 
                        "zip": "5000"
                    }, 
                    "name": "Odense University Hospital"
                }, 
                "investigator": {
                    "last_name": "Mathias Rathe, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Bovine Colostrum on Toxicity and Inflammatory Responses During Treatment of Childhood Acute Lymphoblastic Leukaemia", 
        "overall_contact": {
            "email": "mathias.rathe@ouh.regionsyddanmark.dk", 
            "last_name": "Mathias Rathe, MD", 
            "phone": "+4530296665"
        }, 
        "overall_contact_backup": {
            "email": "steffen.husby@ouh.regionsyddanmark.dk", 
            "last_name": "Steffen Husby, MD, DMSc"
        }, 
        "overall_official": [
            {
                "affiliation": "University og Southern Denmark", 
                "last_name": "Mathias Rathe, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Odense University Hospital", 
                "last_name": "Steffen Husby, MD, DMSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Rigshospitalet, Denmark", 
                "last_name": "Klaus M\u00fcller, MD, DMSc", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Odense University Hospital", 
                "last_name": "Peder S Wehner, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Department of Human Nutrition, Faculty of Life Science, University of Copenhagen, Denmark", 
                "last_name": "Per T Sangild, DVSc, DMSc", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: The Danish National Committee on Biomedical Research Ethics"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Days with temperature at or above 38.5 degrees celsius.", 
            "measure": "Days with fever. Fever", 
            "safety_issue": "No", 
            "time_frame": "Measured two times daily and on suspicion during the intervention period, up to four weeks,"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01766804"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Odense University Hospital", 
            "investigator_full_name": "Steffen Husby", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of days treated in an intensive care unit.", 
                "measure": "Days in intensive care unit", 
                "safety_issue": "No", 
                "time_frame": "During the 4 week intervention period"
            }, 
            {
                "description": "Number of days in intravenous antibiotic treatment during the intervention period.", 
                "measure": "Days in i.v. antibiotic treatment.", 
                "safety_issue": "No", 
                "time_frame": "During the 4 week intervention period."
            }, 
            {
                "measure": "Duration of cytopenia (neutrocytes <1,0 and platelets <20)", 
                "safety_issue": "No", 
                "time_frame": "During the 4 week intervention period."
            }, 
            {
                "description": "Episodes of suspected or culture positive sepsis number of documented septic events either culture proven or those treated with a  course of antibiotics.", 
                "measure": "Proven or suspected infections", 
                "safety_issue": "No", 
                "time_frame": "During the 4 week intervention period"
            }, 
            {
                "description": "Number of blood and platelet transfusions given during the course of treatment", 
                "measure": "Number of blood and platelet transfusions given during the course of treatment", 
                "safety_issue": "No", 
                "time_frame": "During the 4 week intervention period."
            }, 
            {
                "description": "Clinical toxicity is scored using Common Toxicity Criteria for Adverse Effects (NCI-CTCAE), WHO and oral mucositis assessment scale (OMAS) grading schemes at inclusion and weekly during the treatment period. Furthermore the patients register toxicity using the oral mucositis daily questionaire(OMDQ).\nParaclinical indices are citruline, fecal calprotectin,", 
                "measure": "Clinical and paraclinical indices of gastrointestinal toxicity", 
                "safety_issue": "No", 
                "time_frame": "At base line and weekly during the 4 week intervention period. Up to 4 weeks."
            }, 
            {
                "description": "Serum will be taken weekly. Markers will include C reactive protein (CRP), procalcitonin (PCT), soluble urokinase plasminogen activator receptor (sUPAR), plasma cytokines and receptors (IL-6, IL-8, Soluble tumour necrosis factor receptors (sTNFR1), IL-1Ra).\nCytokine production in full blood cultures will be measured at day 3 and at day 24. Initial screening for a broad spectrum of cytokines will be performed in 5-10 patients. Based on these results a final panel of analyses comprising a narrower spectrum of cytokines will be determined and used for further investigation. These will include at least TNFR1, IL-1Ra, IL-6, IL-8.", 
                "measure": "Serologic markers for systemic inflammation", 
                "safety_issue": "No", 
                "time_frame": "Weekly and at day 3 and 24, up to 4 weeks."
            }
        ], 
        "source": "Odense University Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Southern Denmark", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Rigshospitalet, Denmark", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Steffen Husby", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}